Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesRury R. Holman, Adrian F. Hernandez, M. Angelyn Bethel et al.|New England Journal of Medicine|2017Cited by 2.1k
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysisM. Angelyn Bethel, Rury R. Holman, Rishi Patel et al.|The Lancet Diabetes & Endocrinology|2017Cited by 591
Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality MeasurementNeha J. Pagidipati, Thomas A. Gaziano|Circulation|2013Cited by 508
Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery DiseaseKshipra Hemal, Pamela S. Douglas, Neha J. Pagidipati et al.|JACC. Cardiovascular imaging|2016Cited by 163
Risk Factor Burden and Long‐Term Prognosis of Patients With Premature Coronary Artery DiseaseMichel Zeitouni, W. Schuyler Jones, Manesh R. Patel et al.|Journal of the American Heart Association|2020Cited by 159